Hangzhou GluBio Pharmaceutical Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Hangzhou GluBio Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of GLB-001 in Patients With Myeloid Malignancies (NCT06378437) | Hangzhou GluBio Pharmaceutical Co., Ltd. | 2024-05-24 |
| A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas (NCT06219356) | Hangzhou GluBio Pharmaceutical Co., Ltd. | 2024-01-11 |
Track Hangzhou GluBio Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.